Pelvalon announced today that the U.S. Food and Drug Administration (FDA) has granted the company's de novo request to market the Eclipse System, the first vaginal insert designed to provide bowel ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Pelvalon today announced reimbursement for the company’s Eclipse System™ under a new national payment established by the Centers for Medicare and Medicaid ...
Forbes contributors publish independent expert analyses and insights. An award-winning reporter writing about stargazing and the night sky. A new “eclipse season” is upon us, the first since April 8’s ...